119 related articles for article (PubMed ID: 7951006)
1. Polymerase chain reaction (PCR) approach for the evaluation of minimal residual disease in acute leukemia.
Biondi A; Rambaldi A
Stem Cells; 1994 Jul; 12(4):394-401. PubMed ID: 7951006
[TBL] [Abstract][Full Text] [Related]
2. Detection of minimal residual disease in a patient with acute promyelocytic leukemia by RT-PCR: necessity of chemotherapy following ATRA therapy.
Sun T; Takatsuki H; Yamashita S; Yufu Y; Umemura T; Nishimura J; Nawata H
Fukuoka Igaku Zasshi; 1994 Feb; 85(2):52-6. PubMed ID: 8144129
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous detection of type A and type B PML/retinoic acid receptor alpha fusion transcripts in acute promyelocytic leukemia.
Kohli V; Koller CA
Blood; 1995 Feb; 85(3):854-5. PubMed ID: 7833490
[No Abstract] [Full Text] [Related]
4. Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction.
Drexler HG; Borkhardt A; Janssen JW
Leuk Lymphoma; 1995 Nov; 19(5-6):359-80. PubMed ID: 8590836
[TBL] [Abstract][Full Text] [Related]
5. WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia.
Inoue K; Sugiyama H; Ogawa H; Nakagawa M; Yamagami T; Miwa H; Kita K; Hiraoka A; Masaoka T; Nasu K
Blood; 1994 Nov; 84(9):3071-9. PubMed ID: 7949179
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the RT-PCR assay of PML-RARA transcripts in acute promyelocytic leukemia. The Leukemia Study Group of the Ministry of Health and Welfare (Kouseisho).
Fukutani H; Naoe T; Ohno R; Yoshida H; Kiyoi H; Miyawaki S; Morishita H; Sano F; Kamibayashi H; Matsue K
Leukemia; 1995 Apr; 9(4):588-93. PubMed ID: 7723389
[TBL] [Abstract][Full Text] [Related]
7. Reverse transcription-polymerase chain reaction for PML-RAR alpha fusion transcripts in acute promyelocytic leukemia and its application to minimal residual leukemia detection.
Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S
Leukemia; 1993 Apr; 7(4):544-8. PubMed ID: 8385249
[TBL] [Abstract][Full Text] [Related]
8. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
9. Acute promyelocytic leukemia: from clinic to molecular biology.
Chen SJ; Wang ZY; Chen Z
Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
[TBL] [Abstract][Full Text] [Related]
10. Frequent retinoic acid receptor alpha (Rar-alpha) gene rearrangements and no point mutations of N-Ras gene in fifteen cases of acute promyelocytic leukemia.
Arranz E; Santon A; Robledo M; Sánchez-Fayos J; Benítez J
Am J Hematol; 1994 Jun; 46(2):161-2. PubMed ID: 8172191
[No Abstract] [Full Text] [Related]
11. Molecular diagnosis and monitoring of acute promyelocytic leukemia treated with retinoic acid.
Levine K; DeBlasio A; Miller WH
Leukemia; 1994 Apr; 8 Suppl 1():S116-20. PubMed ID: 8152276
[TBL] [Abstract][Full Text] [Related]
12. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
[TBL] [Abstract][Full Text] [Related]
13. Acute promyelocytic leukaemia and the t(15;17) translocation.
Gillard EF; Solomon E
Semin Cancer Biol; 1993 Dec; 4(6):359-67. PubMed ID: 8142621
[TBL] [Abstract][Full Text] [Related]
14. Improved detection of minimal residual leukemia through modifications of polymerase chain reaction analyses based on clonospecific T cell receptor junctions.
Seriu T; Hansen-Hagge TE; Erz DH; Bartram CR
Leukemia; 1995 Feb; 9(2):316-20. PubMed ID: 7869770
[TBL] [Abstract][Full Text] [Related]
15. Genetic changes: relevance for diagnosis and detection of minimal residual disease in acute lymphoblastic leukaemia.
Cole-Sinclair MF; Foroni L; Hoffbrand AV
Baillieres Clin Haematol; 1994 Jun; 7(2):183-233. PubMed ID: 7803899
[TBL] [Abstract][Full Text] [Related]
16. Pulsed-field gel electrophoresis analysis of retinoic acid receptor-alpha and promyelocytic leukemia rearrangements. Detection of the t(15;17) translocation in the diagnosis of acute promyelocytic leukemia.
Xiao YH; Miller WH; Warrell RP; Dmitrovsky E; Zelenetz AD
Am J Pathol; 1993 Nov; 143(5):1301-11. PubMed ID: 8238249
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology of acute promyelocytic leukemia.
Chang KS
Hematol Pathol; 1993; 7(4):209-23. PubMed ID: 8113150
[No Abstract] [Full Text] [Related]
18. [Rearrangement of the alpha RAR and pml genes in promyelocytic leukemia].
Corral Abascal L; Muñiz Fernández A; Alaez Verson C; Hernández Pérez G; Espinosa Martínez E; González Otero A; Hernández Ramírez P; Martínez Antuña G
Sangre (Barc); 1995 Feb; 40(1):71-4. PubMed ID: 7716676
[TBL] [Abstract][Full Text] [Related]
19. [Role of retinoic acid in the treatment of acute promyelocytic leukemia].
Gutiérrez de Guzmán J; Kantarjian H
Sangre (Barc); 1993 Oct; 38(5):375-8. PubMed ID: 8140499
[No Abstract] [Full Text] [Related]
20. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
Chan DW; Liang R; Kwong YL; Chan V
Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
